Linezolid Effects on Bacterial Toxin Production and Host Immune Response: Review of the Evidence

Current Therapeutic Research - Clinical and Experimental

Volumn 73, Issue 3, 2012, Pages 86-102

  Diep, Binh An ^a   Equils, Ozlem ^b   Huang, David B ^b   Gladue, Ron ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PFIZER INC   (United States)

Author keywords

Bacterial toxin; Immune modulation; Inflammation; Linezolid

Indexed keywords

ALPHA HEMOLYSIN; AUTOLYSIN; AZITHROMYCIN; BACTERIAL TOXIN; BETA HEMOLYSIN; CHLORAMPHENICOL; CLINDAMYCIN; COAGULASE; COTRIMOXAZOLE; DAPTOMYCIN; DEOXYRIBONUCLEASE; ERYTHROMYCIN; EXOTOXIN; KANAMYCIN; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; PROTEIN A; PROTEIN M2; PROTEIN SYNTHESIS INHIBITOR; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS TOXIN; STREPTOLYSIN O; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

BACTERIAL IMMUNITY; BACTERIOLYSIS; BIBLIOGRAPHIC DATABASE; CYTOKINE RELEASE; DRUG EFFECT; DRUG RESPONSE; HISTOPATHOLOGY; HUMAN; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INFORMATION RETRIEVAL; LUNG INFECTION; MEDLINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INHIBITOR OF COMPLEMENT MEDIATED LYSIS; STREPTOCOCCUS PYOGENES; TOXIN SYNTHESIS;

EID: 84861825576     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.curtheres.2012.04.002     Document Type: Review

References (42)

1. Van Amersfoort E.S., Van Berkel T.J., Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003, 16:379-414.
2. Arditi M., Kabat W., Yogev R. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J Infect Dis 1993, 167:240-244.
3. Mattsson E., Van Dijk H., Verhoef J., et al. Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes. Infect Immun 1996, 64:4351-4355.
4. Simon D.M., Koenig G., Trenholme G.M. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J Infect Dis 1991, 164:800-802.
5. Nau R., Eiffert H. Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev 2002, 15:95-110.
6. Rouzic N., Janvier F., Libert N., et al. Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes. J Clin Microbiol 2010, 48:1952-1955.
7. ZYVOX [package insert] 2010, Pfizer Inc, New York, NY.
8. Herrmann D.J., Peppard W.J., Ledeboer N.A., et al. Linezolid for the treatment of drug-resistant infections. Expert Rev Anti Infect Ther 2008, 6:825-848.
9. Dumitrescu O., Badiou C., Bes M., et al. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect 2008, 14:384-388.
10. Dumitrescu O., Boisset S., Badiou C., et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother 2007, 51:1515-1519.
11. Stevens D.L., Ma Y., Salmi D.B., et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 2007, 195:202-211.
12. Stevens D.L., Wallace R.J., Hamilton S.M., Bryant A.E. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Clin Infect Dis 2006, 42:729-730.
13. Bocchini C.E., Hulten K.G., Mason E.O., et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 2006, 117:433-440.
14. Dohin B., Gillet Y., Kohler R., et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 2007, 26:1042-1048.
15. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
16. Montgomery C.P., Daum R.S. Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for Panton-Valentine leukocidin?. Infect Immun 2009, 77:2159-2167.
17. Yamasaki O., Kaneko J., Morizane S., et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 2005, 40:381-385.
18. Wang R., Braughton K.R., Kretschmer D., et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007, 13:1510-1514.
19. Joo H.S., Chan J.L., Cheung G.Y., Otto M. Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010, 54:4942-4944.
20. Yarwood J.M., Schlievert P.M. Quorum sensing in Staphylococcus infections. J Clin Invest 2003, 112:1620-1625.
21. Gemmell C.G., Ford C.W. Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid. J Antimicrob Chemother 2002, 50:665-672.
22. Bernardo K., Pakulat N., Fleer S., et al. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 2004, 48:546-555.
23. Tanaka M., Hasegawa T., Okamoto A., et al. Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis. Antimicrob Agents Chemother 2005, 49:88-96.
24. Coyle E.A., Cha R., Rybak M.J. Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob Agents Chemother 2003, 47:1752-1755.
25. Pascual A., Ballesta S., Garcia I., Perea E.J. Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells. Antimicrob Agents Chemother 2002, 46:4013-4015.
26. Ballesta S., Pascual A., Garcia I., Perea E.J. Effect of linezolid on the phagocytic functions of human polymorphonuclear leukocytes. Chemotherapy 2003, 49:163-166.
27. Naess A., Stenhaug Kilhus K., Nystad T.W., Sornes S. Linezolid and human polymorphonuclear leukocyte function. Chemotherapy 2006, 52:122-124.
28. Krakauer T. Immune response to staphylococcal superantigens. Immunol Res 1999, 20:163-173.
29. Kushiya K., Nakagawa S., Taneike I., et al. Inhibitory effect of antimicrobial agents and anisodamine on the staphylococcal superantigenic toxin-induced overproduction of proinflammatory cytokines by human peripheral blood mononuclear cells. J Infect Chemother 2005, 11:192-195.
30. Pichereau S., Moran J.J., Hayney M.S., et al. Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells. J Antimicrob Chemother 2012, 67:123-129.
31. Garcia-Roca P., Mancilla-Ramirez J., Santos-Segura A., et al. Linezolid diminishes inflammatory cytokine production from human peripheral blood mononuclear cells. Arch Med Res 2006, 37:31-35.
32. Takahashi G., Sato N., Yaegashi Y., et al. Effect of linezolid on cytokine production capacity and plasma endotoxin levels in response to lipopolysaccharide stimulation of whole blood. J Infect Chemother 2010, 16:94-99.
33. Lambers C., Burian B., Binder P., et al. Early immunomodulatory effects of linezolid in a human whole blood endotoxin model. Int J Clin Pharmacol Ther 2010, 48:419-424.
34. Yanagihara K., Kaneko Y., Sawai T., et al. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob Agents Chemother 2002, 46:3288-3291.
35. Yanagihara K., Kihara R., Araki N., et al. Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive methicillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection. Int J Antimicrob Agents 2009, 34:477-481.
36. Akinnusi M.E., Hattemer A., Gao W., El-Solh A.A. Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia?. Crit Care Med 2011, 39:1944-1952.
37. Luna C.M., Bruno D.A., Garcia-Morato J., et al. Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets. Chest 2009, 135:1564-1571.
38. Martinez-Olondris P., Rigol M., Soy D., et al. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs. Crit Care Med 2012, 40:162-168.
39. Aytan H., Caliskan A.C., Yener T., et al. A novel antibiotic, linezolid, reduces intraperitoneal adhesion formation in the rat uterine horn model. Acta Obstet Gynecol Scand 2009, 88:781-786.
40. van der Wal J.B., Jeekel J. Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal Dis 2007, 9(Suppl 2):9-13.
41. Danin J., Linder L., Lundqvist G., Wretlind B. Cytokines in periradicular lesions: the effect of linezolid treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 96:492-498.
42. Herbert S., Barry P., Novick R.P. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect Immun 2001, 69:2996-3003.